Solace, a digital platform connecting patients with professional healthcare advocates, announced a $60 million Series B round. The raise marks a strong vote of confidence in the company’s mission to make advocacy an expected and reimbursable part of the care journey.
Menlo Ventures led the round, joined by existing investors Craft Ventures, Inspired Capital, and Torch Capital. SignalFire also joined as a new backer. The latest capital injection brings Solace’s total funding to date to over $85 million.
Healthcare in the U.S. remains highly fragmented, often leaving patients to navigate complex systems on their own. Solace is betting that a new category—tech-enabled, human-driven advocacy—will reshape how care is delivered. The company’s growth reflects an increasing acknowledgment among insurers and providers that support services aren't optional—they’re structural.
“The healthcare industry is at a tipping point. Payers increasingly recognize that patient advocacy isn't a support function. It's structurally necessary," said Jeremy Gurewitz, CEO and co-founder of Solace.
With the new funds, Solace plans to double down on product development and user experience improvements. Its proprietary EHR and data platform simplifies care navigation and reduces administrative friction for patients and advocates alike.
The investment will also support the expansion of Solace’s national advocate network, which already spans all 50 U.S. states. Solace is covered by Medicare and major Medicare Advantage insurers including Aetna, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealthcare.
Solace was founded in 2022 by Jeremy Gurewitz and Sara Sargent, both driven by personal experiences with the inefficiencies of the U.S. healthcare system. Their vision: a patient-first approach where expert advocates guide care decisions, coordinate treatments, and ensure continuity across the entire healthcare journey.
"Solace delivers what legacy systems can’t," said Sara Sargent, Chief Product Officer and co-founder. "Personalized, tech-enabled advocacy that scales. Our platform anticipates needs, guides decisions in real time, and makes advocacy an integral part of every patient’s experience."
The company’s services are covered by insurance, making them more accessible to the millions who typically face the healthcare system alone.
Menlo Ventures joins a solid group of returning investors who have backed Solace since its early days. Craft Ventures, Inspired Capital, and Torch Capital have supported the company's mission to modernize healthcare navigation from the beginning. SignalFire’s entry into the investor group underscores the growing interest in technology-enabled care models.
“Our investment in Solace underscores our conviction that healthcare advocacy will quickly become a core component of modern healthcare delivery,” said JP Sanday, Partner at Menlo Ventures.
